Paper37875111
Methotrexate-based PROTACs as DHFR-specific chemical probes.
Rana S and 16 others. Cell Chem Biol, 2024. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Methotrexate-based PROTACs as DHFR-specific chemical probes. Papers, record 37875111. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37875111
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Intramural, Research Support, N.I.H., Extramural
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Folic Acid Antagonists | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Carbon | |
| Methotrexate | |
| Proteolysis Targeting Chimera | |
| Tetrahydrofolate Dehydrogenase |
Source PubMed
Grants10
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R43 TR000471 | NCATS NIH HHS | United States | R43TR000471 | PubMed and NIH | NIH RePORTER |
| R01 CA256911 | NCI NIH HHS | United States | R01CA256911 | PubMed and NIH | NIH RePORTER |
| R01 CA163649 | NCI NIH HHS | United States | R01CA163649 | PubMed and NIH | NIH RePORTER |
| R01 CA270234 | NCI NIH HHS | United States | R01CA270234 | PubMed and NIH | NIH RePORTER |
| Z01 BC009287 | Intramural NIH HHS | United States | ZIABC009287 | PubMed and NIH | NIH RePORTER |
| ZIA BC009287 | Intramural NIH HHS | United States | ZIABC009287 | PubMed and NIH | NIH RePORTER |
| ZIA TR000053 | Intramural NIH HHS | United States | ZIATR000053 | PubMed | NIH RePORTER |
| U54 CA274329 | NCI NIH HHS | United States | U54CA274329 | PubMed and NIH | NIH RePORTER |
| ZIATR000471 | NIH | NIH RePORTER | |||
| ZICTR000037 | NIH | NIH RePORTER |
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36135 | Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase. | Biochemistry | 1979 | https://conductscience.org/library/papers/36135 | PubMed |
| 2 | 31715132 | A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo. | Cancer Cell | 2019 | https://conductscience.org/library/papers/31715132 | PubMed |
| 3 | 20129059 | Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ. | Mol Cell | 2010 | https://conductscience.org/library/papers/20129059 | PubMed |
| 4 | 17289560 | Chemical genetics: where genetics and pharmacology meet. | Cell | 2007 | https://conductscience.org/library/papers/17289560 | PubMed |
| 5 | 1167807 | Mechanism of growth inhibition by methotrexate. | Cancer Res | 1975 | https://conductscience.org/library/papers/1167807 | PubMed |
| 6 | 30444612 | Addressing Kinase-Independent Functions of Fak via PROTAC-Mediated Degradation. | J Am Chem Soc | 2018 | https://conductscience.org/library/papers/30444612 | PubMed |
| 7 | 565818 | Methotrexate analogues. 11. Unambiguous chemical synthesis and in vitro biological evaluation of alpha- and gamma-monoesters as potential prodrugs. | J Med Chem | 1978 | https://conductscience.org/library/papers/565818 | PubMed |
| 8 | 4213249 | Methotrexate analogs. 3. Synthesis and biological properties of some side-chain altered analogs. | J Med Chem | 1974 | https://conductscience.org/library/papers/4213249 | PubMed |
| 9 | 16572121 | A loss-of-function RNA interference screen for molecular targets in cancer. | Nature | 2006 | https://conductscience.org/library/papers/16572121 | PubMed |
| 10 | 26051217 | Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. | Chem Biol | 2015 | https://conductscience.org/library/papers/26051217 | PubMed |
| 11 | 29772907 | Revisiting the "Art of the Chemical Probe". | ACS Chem Biol | 2018 | https://conductscience.org/library/papers/29772907 | PubMed |
| 12 | 35779262 | RNA interference protocol to silence oncogenic drivers in leukemia cell lines. | STAR Protoc | 2022 | https://conductscience.org/library/papers/35779262 | PubMed |
| 13 | 17429427 | ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? | Leukemia | 2007 | https://conductscience.org/library/papers/17429427 | PubMed |
| 14 | 7605998 | Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations. | Blood | 1995 | https://conductscience.org/library/papers/7605998 | PubMed |
| 15 | 2248959 | Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate. | Biochemistry | 1990 | https://conductscience.org/library/papers/2248959 | PubMed |
| 16 | 35042991 | PROTAC targeted protein degraders: the past is prologue. | Nat Rev Drug Discov | 2022 | https://conductscience.org/library/papers/35042991 | PubMed |
| 17 | 33707653 | Folate metabolism: a re-emerging therapeutic target in haematological cancers. | Leukemia | 2021 | https://conductscience.org/library/papers/33707653 | PubMed |
| 18 | 33406420 | Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins. | Cell Rep | 2021 | https://conductscience.org/library/papers/33406420 | PubMed |
| 19 | 17637769 | Reporting data from high-throughput screening of small-molecule libraries. | Nat Chem Biol | 2007 | https://conductscience.org/library/papers/17637769 | PubMed |
| 20 | 3278183 | The chemistry of methotrexate and its analogues. | Med Res Rev | 1988 | https://conductscience.org/library/papers/3278183 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42346097 | Structure-Based Virtual Screening and Mechanistic Characterization of Methotrexate and Selinexor as Potent Anti-Melanogenic Agents via Multi-Pathway Suppression of MITF. | Cells | 2026 | https://conductscience.org/library/papers/42346097 | PubMed |
| 42262317 | Engineering Protein Stability with Small Molecules: A Review of the ecDHFR Destabilizing Domain System. | ACS Chem Biol | 2026 | https://conductscience.org/library/papers/42262317 | PubMed |
| 42072629 | Label-Free Target Discovery Strategy for Natural Active Products. | Biomolecules | 2026 | https://conductscience.org/library/papers/42072629 | PubMed |
| 42009164 | Polyploid cancer cells surviving cisplatin reallocate central carbon sources to fuel antioxidant metabolism for survival. | Mol Metab | 2026 | https://conductscience.org/library/papers/42009164 | PubMed |
| 41950802 | Emerging mechanistic trends and clinical efficacy for methotrexate: Applications to inflammatory bowel disease. | Pharmacol Rev | 2026 | https://conductscience.org/library/papers/41950802 | PubMed |
| 41542490 | Drug-tolerant persister cells reallocate carbon sources to fuel antioxidant metabolism for survival. | bioRxiv | 2026 | https://conductscience.org/library/papers/41542490 | PubMed |
| 41502523 | ELK4 Promotes Vasculogenic Mimicry in Oral Squamous Cell Carcinoma via Driving DHFR Transcriptional Activation. | Oncol Res | 2025 | https://conductscience.org/library/papers/41502523 | PubMed |
| 41389337 | One-carbon metabolism in cancer: moonlighting functions of metabolic enzymes and anti-tumor therapy. | Cancer Metastasis Rev | 2025 | https://conductscience.org/library/papers/41389337 | PubMed |
| 41155332 | New Insights into Pathogenesis and Management of Keratoacanthoma: A Narrative Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41155332 | PubMed |
| 40626313 | Utilizing small molecules to probe and harness the proteome by pooled protein tagging with ligandable domains. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40626313 | PubMed |
| 40468924 | Innovative Therapies for Oncogenic KRAS Mutations: Precision Strategies with PROTACs in Cancer Treatment. | Anticancer Agents Med Chem | 2026 | https://conductscience.org/library/papers/40468924 | PubMed |
| 40346061 | A general assay platform to study protein pharmacology using ligand-dependent structural dynamics. | Nat Commun | 2025 | https://conductscience.org/library/papers/40346061 | PubMed |
| 40270992 | Combating Methotrexate Resistance in Cancer Treatment: A Review on Navigating Pathways and Enhancing Its Efficacy With Fat-Soluble Vitamins. | Scientifica (Cairo) | 2025 | https://conductscience.org/library/papers/40270992 | PubMed |
| 40045315 | An anti-CD19-exosome delivery system navigates the blood-brain barrier for targeting of central nervous system lymphoma. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40045315 | PubMed |
| 39371335 | Exploration of the link between COVID-19 and gastric cancer from the perspective of bioinformatics and systems biology. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39371335 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| DHFR | 1719 | PubTator's text mining | https://conductscience.org/library/genes/1719 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37875111
GET https://conductscience.org/api/papers/v1/37875111/references?page=2